Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
63,013,241
-
Total 13F shares
-
9,938,360
-
Share change
-
+991,651
-
Total reported value
-
$76,782,098
-
Put/Call ratio
-
137%
-
Price per share
-
$7.73
-
Number of holders
-
79
-
Value change
-
+$8,994,470
-
Number of buys
-
46
-
Number of sells
-
29
Institutional Holders of Cytosorbents Corp - Common Stock (CTSO) as of Q1 2020
As of 31 Mar 2020,
Cytosorbents Corp - Common Stock (CTSO) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,938,360 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Skylands Capital, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, STATE STREET CORP, Sargent Investment Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, MORGAN STANLEY, and RAYMOND JAMES & ASSOCIATES.
This page lists
79
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.